Tag: Covid-19
-
RNA Manufacturer Goes Public in $282M Merger
A company producing synthetic RNA for agricultural and biomedical applications is now a public company after a special-purpose acquisition.
-
Moderna to Build mRNA Vaccine Plant in Canada
The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada.
-
Portable Testing Device IDs Covid-19 Variants
A low-cost device is being developed that analyzes saliva samples for SARS-CoV-2 viral mutations, and returns results in about one hour.
-
Tech Shaping the Post-Covid Healthcare Landscape
Tech adopted during the pandemic looks set to continue as we transition into a world where the virus doesn’t control us.
-
Sanofi Acquires mRNA Developer in $3.2B Deal
Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and therapies, and a long-time collaborator.
-
Infographic – Majorities Favor U.S. Vaccine Mandates
As the more contagious delta variant becomes the dominant SARS-CoV-2 strain, a clear majority of American adults now favors employers mandating Covid-19 vaccines.
-
Covid-19 Delta Variant Testing Reference Released
A company designing synthetic DNA and RNA says reference materials are available for tests that detect the quickly spreading Covid-19 delta variant.
-
Pooled Saliva Tests Detect Covid-19 in Schools
Combining commercial saliva tests to speed detection of the SARS-CoV-2 virus in schools is shown as accurate as individual gold-standard nasal swab tests.
-
$60M Challenge Seeks RNA Bio-Production Network
A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products.
-
Fitness Tracker Data Show Longer Covid-19 Effects
Data collected from wearable activity trackers show extended cardiac effects in people with Covid-19 infections, in some cases for several months.